Medical DeviceNews

Royal Philips announces 1500+ Cath Lab installations in Indian subcontinent

Announced the launch of two groundbreaking products to address the burden of cardiovascular disease (CVD) in India

Royal Philips announced that it has 1500+ Cath Lab (interventional suite) installations in the Indian subcontinent. The completion of 1500+ Cath Lab installations marks a major milestone in Philips’ mission to create innovative solutions designed to meet the company’s Quadruple Aim of better health outcomes, improved patient experience, improved staff experience, and lower cost of care. Over the last quarter, the company has installed its state-of-the-art Azurion Cath Labs at major sites across the country including in cities such as Delhi, Bengaluru, Mumbai, Kolkata, Hyderabad, Chennai, and Pune amongst others.

Philips also announced the launch of two groundbreaking products to address the burden of cardiovascular disease (CVD) in India. OmniWire, the world’s first solid core pressure wire for coronary artery interventional procedures was introduced in India. With its breakthrough solid core construction, physicians can more easily manoeuvre the wire in the patient’s circulatory system to measure blood pressure along the vessel and guide the delivery of catheters and stents.

The company also launched its latest Image Guided Therapy Mobile C-arm System – Zenition 90 Motorized, which is designed to help surgeons deliver high-quality care to patients. The new mobile C-arm with expanded capabilities is designed to not only meet complex vascular needs but also a range of clinical procedures such as cardiac interventions, pain management and urology.

“The successful installation of 1500+ Cath lab in the Indian Subcontinent and the launch of OmniWire and Zenition 90 Motorised are momentous as they signify both our commitment to innovation and our enduring support to the health ecosystem in India. Signifying the best in innovation from Philips, these products provide doctors with technologies that ensure better outcomes for both patients and caregivers. As we look to improve the delivery of care in the country, Philips remains committed to remaining an able partner to the government in meeting its healthcare goals,” said Daniel Mazon, Vice Chairman and Managing Director, Philips Indian Subcontinent.

 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Back to top button
IndiaMedToday
Close
Close